Article Details
Retrieved on: 2021-06-15 23:37:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
In addition, Inhibikase has granted the underwriters a 45-day option to purchase up to 2.25 million additional shares of common stock at the public ...
Article found on: www.prnewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here